Skip to Content

TV TV L2 L2 (Lamivudine and Zidovudine 150 mg / 300 mg)

Pill with imprint TV TV L2 L2 is White, Elliptical / Oval and has been identified as Lamivudine and Zidovudine 150 mg / 300 mg. It is supplied by Teva Pharmaceuticals USA Inc..

Lamivudine/zidovudine is used in the treatment of hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Lamivudine/zidovudine 150 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TV TV L2 L2

Lamivudine and zidovudine 150 mg / 300 mg TV TV L2 L2
Lamivudine and zidovudine 150 mg / 300 mg TV TV L2 L2
Lamivudine and zidovudine 150 mg / 300 mg TV TV L2 L2
Lamivudine and zidovudine 150 mg / 300 mg TV TV L2 L2

Lamivudine and Zidovudine

Imprint
TV TV L2 L2
Strength
150 mg / 300 mg
Color
White
Size
17.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Antiviral combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA Inc.
Inactive Ingredients
hypromellose 2910 (3 mPa.s), hypromellose 2910 (6 mPa.s), magnesium stearate, microcrystalline cellulose, polyethylene glycol 400, polysorbate 80, sodium starch glycolate type A potato, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00093-5385 Teva Pharmaceuticals USA, Inc.
42291-0363 AvKare, Inc.

Get help with Imprint Code FAQs.

Related Images for "TV TV L2 L2"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.